U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07671157) titled 'Phase 2 Open Label Trial of Delgocitinib 20 mg/g Cream in Subjects With Frontal Fibrosing Alopecia (FFA)' on June 22.
Brief Summary: This research study is a Phase II clinical trial. Phase II clinical trials test the safety and effectiveness of an investigational study drug to learn whether the delgocitinib 20 mg/g cream works in treating a specific disease. "Investigational" means that the delgocitinib 20 mg/g cream is being studied.
Study Start Date: Sept. 10, 2026
Study Type: INTERVENTIONAL
Condition:
Frontal Fibrosing Alopecia
Intervention:
DRUG: Delgocitinib
Everyone in this study receives the study drug (delgocitinib)
...